EDITGENE Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.39M

  • Investors
  • 3

EDITGENE General Information

Description

Developer of gene editing technology designed for Biotechnology. The company's products mainly focus on developing and optimizing CRISPR/Cas-based (clustered regularly interspaced short palindromic repeats) genome editing technologies. It relies on monoclonal printing platforms, providing customers with efficient and precise gene editing services.

Contact Information

Website
www.edgene.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 501, Building D, Guangzhou International Business Incubator
  • No. 3 Juquan Road, Science City, Huangpu District
  • Guangzhou, Guangdong
  • China
+86 181
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Room 501, Building D, Guangzhou International Business Incubator
  • No. 3 Juquan Road, Science City, Huangpu District
  • Guangzhou, Guangdong
  • China
+86 181

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EDITGENE Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 12-Mar-2024 $1.39M Completed Generating Revenue
To view EDITGENE’s complete valuation and funding history, request access »

EDITGENE Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Qianhai Great Wall Fund Management (Shenzhen) Growth/Expansion Minority
Yanghe Investment Venture Capital Minority
Zhongda Venture Capital Venture Capital Minority
To view EDITGENE’s complete investors history, request access »

EDITGENE FAQs

  • When was EDITGENE founded?

    EDITGENE was founded in 2017.

  • Where is EDITGENE headquartered?

    EDITGENE is headquartered in Guangzhou, China.

  • What industry is EDITGENE in?

    EDITGENE’s primary industry is Biotechnology.

  • Is EDITGENE a private or public company?

    EDITGENE is a Private company.

  • What is EDITGENE’s current revenue?

    The current revenue for EDITGENE is .

  • How much funding has EDITGENE raised over time?

    EDITGENE has raised $1.39M.

  • Who are EDITGENE’s investors?

    Qianhai Great Wall Fund Management (Shenzhen), Yanghe Investment, and Zhongda Venture Capital have invested in EDITGENE.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process